Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Enterprise Value (2016 - 2018)

Armata Pharmaceuticals' Enterprise Value history spans 6 years, with the latest figure at -$13.4 million for Q3 2018.

  • For Q3 2018, Enterprise Value fell 73.37% year-over-year to -$13.4 million; the TTM value through Sep 2018 reached -$13.4 million, down 73.37%, while the annual FY2017 figure was -$5.1 million, 0.0% changed from the prior year.
  • Enterprise Value for Q3 2018 was -$13.4 million at Armata Pharmaceuticals, up from -$15.4 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$2.2 million in Q1 2017 and bottomed at -$16.6 million in Q1 2015.
  • The 5-year median for Enterprise Value is -$8.6 million (2017), against an average of -$9.5 million.
  • The largest YoY upside for Enterprise Value was 67.67% in 2014 against a maximum downside of 2185.81% in 2014.
  • A 5-year view of Enterprise Value shows it stood at -$6.6 million in 2014, then plummeted by 78.35% to -$11.7 million in 2015, then soared by 56.28% to -$5.1 million in 2016, then changed by 0.0% to -$5.1 million in 2017, then crashed by 160.97% to -$13.4 million in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Enterprise Value are -$13.4 million (Q3 2018), -$15.4 million (Q2 2018), and -$8.2 million (Q1 2018).